Drugs / Wharton Jelly Originated Mesencimal Stem Cell
last change Dec 2020 re-read 3 minutes ago

Wharton Jelly Originated Mesencimal Stem Cell

Developed for
osteoarthritis, knee
Investigated by
TC Erciyes University

Trials 1

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04313894 Jan → Dec 2019 osteoarthritis, knee TC Erciyes University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Wharton Jelly Originated Mesencimal Stem Cell ClinicalTrials.gov intervention name — accepted as the source's own label NCT04313894 ↗